Global Pulmonary Drug Delivery Systems Market Insights, Forecast to 2025

Publisher Name :
Date: 01-Feb-2019
No. of pages: 123
Inquire Before Buying

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.

As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.

The global Pulmonary Drug Delivery Systems market is valued at 2560 million US$ in 2018 and will reach 3570 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pulmonary Drug Delivery Systems market based on company, product type, end user and key regions.

This report studies the global market size of Pulmonary Drug Delivery Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pulmonary Drug Delivery Systems in these regions.

This research report categorizes the global Pulmonary Drug Delivery Systems market by top players/brands, region, type and end user. This report also studies the global Pulmonary Drug Delivery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- 3M

- GSK

- AstraZeneca

- Cipla

- Chiesi

- Boehringer Ingelheim

- Aptar

- Novartis

- Philips Respironics

- Omron Healthcare

- PARI

- Skyepharma

- CareFusion

- Shanghai Huarui

- Taian Character

- Chia Tai Tianqing

Market size by Product

- Nebulizers

- Dry Powder Inhaler (DPI)

- Metered Dose Inhaler (MDI)

Market size by End User

- COPD

- Asthma

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Pulmonary Drug Delivery Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Pulmonary Drug Delivery Systems market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Pulmonary Drug Delivery Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Pulmonary Drug Delivery Systems submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pulmonary Drug Delivery Systems are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pulmonary Drug Delivery Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Pulmonary Drug Delivery Systems Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Pulmonary Drug Delivery Systems Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Product
1.4.2 Nebulizers
1.4.3 Dry Powder Inhaler (DPI)
1.4.4 Metered Dose Inhaler (MDI)
1.5 Market by End User
1.5.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by End User
1.5.2 COPD
1.5.3 Asthma
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pulmonary Drug Delivery Systems Market Size
2.1.1 Global Pulmonary Drug Delivery Systems Revenue 2014-2025
2.1.2 Global Pulmonary Drug Delivery Systems Sales 2014-2025
2.2 Pulmonary Drug Delivery Systems Growth Rate by Regions
2.2.1 Global Pulmonary Drug Delivery Systems Sales by Regions
2.2.2 Global Pulmonary Drug Delivery Systems Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pulmonary Drug Delivery Systems Sales by Manufacturers
3.1.1 Pulmonary Drug Delivery Systems Sales by Manufacturers
3.1.2 Pulmonary Drug Delivery Systems Sales Market Share by Manufacturers
3.1.3 Global Pulmonary Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2 Pulmonary Drug Delivery Systems Revenue by Manufacturers
3.2.1 Pulmonary Drug Delivery Systems Revenue by Manufacturers (2014-2019)
3.2.2 Pulmonary Drug Delivery Systems Revenue Share by Manufacturers (2014-2019)
3.3 Pulmonary Drug Delivery Systems Price by Manufacturers
3.4 Pulmonary Drug Delivery Systems Manufacturing Base Distribution, Product Types
3.4.1 Pulmonary Drug Delivery Systems Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pulmonary Drug Delivery Systems Product Type
3.4.3 Date of International Manufacturers Enter into Pulmonary Drug Delivery Systems Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pulmonary Drug Delivery Systems Sales by Product
4.2 Global Pulmonary Drug Delivery Systems Revenue by Product
4.3 Pulmonary Drug Delivery Systems Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pulmonary Drug Delivery Systems Breakdown Data by End User
6 North America
6.1 North America Pulmonary Drug Delivery Systems by Countries
6.1.1 North America Pulmonary Drug Delivery Systems Sales by Countries
6.1.2 North America Pulmonary Drug Delivery Systems Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pulmonary Drug Delivery Systems by Product
6.3 North America Pulmonary Drug Delivery Systems by End User
7 Europe
7.1 Europe Pulmonary Drug Delivery Systems by Countries
7.1.1 Europe Pulmonary Drug Delivery Systems Sales by Countries
7.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pulmonary Drug Delivery Systems by Product
7.3 Europe Pulmonary Drug Delivery Systems by End User
8 Asia Pacific
8.1 Asia Pacific Pulmonary Drug Delivery Systems by Countries
8.1.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Countries
8.1.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pulmonary Drug Delivery Systems by Product
8.3 Asia Pacific Pulmonary Drug Delivery Systems by End User
9 Central & South America
9.1 Central & South America Pulmonary Drug Delivery Systems by Countries
9.1.1 Central & South America Pulmonary Drug Delivery Systems Sales by Countries
9.1.2 Central & South America Pulmonary Drug Delivery Systems Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pulmonary Drug Delivery Systems by Product
9.3 Central & South America Pulmonary Drug Delivery Systems by End User
10 Middle East and Africa
10.1 Middle East and Africa Pulmonary Drug Delivery Systems by Countries
10.1.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Countries
10.1.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pulmonary Drug Delivery Systems by Product
10.3 Middle East and Africa Pulmonary Drug Delivery Systems by End User
11 Company Profiles
11.1 3M
11.1.1 3M Company Details
11.1.2 Company Business Overview
11.1.3 3M Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.1.4 3M Pulmonary Drug Delivery Systems Products Offered
11.1.5 3M Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GSK Pulmonary Drug Delivery Systems Products Offered
11.2.5 GSK Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 Company Business Overview
11.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AstraZeneca Pulmonary Drug Delivery Systems Products Offered
11.3.5 AstraZeneca Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Company Business Overview
11.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cipla Pulmonary Drug Delivery Systems Products Offered
11.4.5 Cipla Recent Development
11.5 Chiesi
11.5.1 Chiesi Company Details
11.5.2 Company Business Overview
11.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Chiesi Pulmonary Drug Delivery Systems Products Offered
11.5.5 Chiesi Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Company Business Overview
11.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Products Offered
11.6.5 Boehringer Ingelheim Recent Development
11.7 Aptar
11.7.1 Aptar Company Details
11.7.2 Company Business Overview
11.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Aptar Pulmonary Drug Delivery Systems Products Offered
11.7.5 Aptar Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis Pulmonary Drug Delivery Systems Products Offered
11.8.5 Novartis Recent Development
11.9 Philips Respironics
11.9.1 Philips Respironics Company Details
11.9.2 Company Business Overview
11.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Philips Respironics Pulmonary Drug Delivery Systems Products Offered
11.9.5 Philips Respironics Recent Development
11.10 Omron Healthcare
11.10.1 Omron Healthcare Company Details
11.10.2 Company Business Overview
11.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Products Offered
11.10.5 Omron Healthcare Recent Development
11.11 PARI
11.12 Skyepharma
11.13 CareFusion
11.14 Shanghai Huarui
11.15 Taian Character
11.16 Chia Tai Tianqing
12 Future Forecast
12.1 Pulmonary Drug Delivery Systems Market Forecast by Regions
12.1.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Regions 2019-2025
12.1.2 Global Pulmonary Drug Delivery Systems Revenue Forecast by Regions 2019-2025
12.2 Pulmonary Drug Delivery Systems Market Forecast by Product
12.2.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Product 2019-2025
12.2.2 Global Pulmonary Drug Delivery Systems Revenue Forecast by Product 2019-2025
12.3 Pulmonary Drug Delivery Systems Market Forecast by End User
12.4 North America Pulmonary Drug Delivery Systems Forecast
12.5 Europe Pulmonary Drug Delivery Systems Forecast
12.6 Asia Pacific Pulmonary Drug Delivery Systems Forecast
12.7 Central & South America Pulmonary Drug Delivery Systems Forecast
12.8 Middle East and Africa Pulmonary Drug Delivery Systems Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pulmonary Drug Delivery Systems Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Pulmonary Drug Delivery Systems Product Picture
Table Pulmonary Drug Delivery Systems Market Segments
Table Key Manufacturers Pulmonary Drug Delivery Systems Covered
Table Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Product 2019-2025 (M Units) & (Million US$)
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Product 2014-2025
Figure Nebulizers Product Picture
Table Major Manufacturers of Nebulizers
Figure Dry Powder Inhaler (DPI) Product Picture
Table Major Manufacturers of Dry Powder Inhaler (DPI)
Figure Metered Dose Inhaler (MDI) Product Picture
Table Major Manufacturers of Metered Dose Inhaler (MDI)
Table Global Pulmonary Drug Delivery Systems Market Size Growth Rate by End User 2019-2025 (M Units)
Figure COPD
Figure Asthma
Figure Others
Figure Pulmonary Drug Delivery Systems Report Years Considered
Figure Global Pulmonary Drug Delivery Systems Market Size 2014-2025 (Million US$)
Figure Global Pulmonary Drug Delivery Systems Sales 2014-2025 (M Units)
Table Global Pulmonary Drug Delivery Systems Market Size by Regions 2014-2019 (M Units) & (Million US$)
Table Global Pulmonary Drug Delivery Systems Sales by Regions 2014-2019 (M Units)
Table Global Pulmonary Drug Delivery Systems Sales Market Share by Regions 2014-2019
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Regions 2014-2019
Figure 2018 Global Pulmonary Drug Delivery Systems Sales Market Share by Regions
Table Global Pulmonary Drug Delivery Systems Revenue by Regions 2014-2019 (Million US$)
Table Global Pulmonary Drug Delivery Systems Revenue Market Share by Regions 2014-2019
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Regions 2014-2019
Figure 2018 Global Pulmonary Drug Delivery Systems Revenue Market Share by Regions
Table Global Pulmonary Drug Delivery Systems Sales by Manufacturers (2014-2019) (M Units)
Table Global Pulmonary Drug Delivery Systems Sales Share by Manufacturers (2014-2019)
Figure Global Pulmonary Drug Delivery Systems Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Pulmonary Drug Delivery Systems Revenue by Manufacturers (2014-2019) (Million USD)
Table Pulmonary Drug Delivery Systems Revenue Share by Manufacturers (2014-2019)
Figure Pulmonary Drug Delivery Systems Value Share by Manufacturers in 2018
Table Key Manufacturers Pulmonary Drug Delivery Systems Price (2014-2019) (USD/Unit)
Table Pulmonary Drug Delivery Systems Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pulmonary Drug Delivery Systems Product Type
Table Date of International Manufacturers Enter into Pulmonary Drug Delivery Systems Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pulmonary Drug Delivery Systems Sales by Product (2014-2019) (M Units)
Table Global Pulmonary Drug Delivery Systems Sales Share by Product (2014-2019)
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Product (2014-2019)
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Product in 2018
Table Global Pulmonary Drug Delivery Systems Revenue by Product (2014-2019) (Million US$)
Table Global Pulmonary Drug Delivery Systems Revenue Share by Product (2014-2019)
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Product (2014-2019)
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Product in 2018
Table Pulmonary Drug Delivery Systems Price by Product 2014-2019 (USD/Unit)
Table Global Pulmonary Drug Delivery Systems Sales by End User (2014-2019) (M Units)
Table Global Pulmonary Drug Delivery Systems Sales Share by End User (2014-2019)
Figure Global Sales Pulmonary Drug Delivery Systems Market Share by End User (2014-2019)
Figure Global Sales Pulmonary Drug Delivery Systems Market Share by End User in 2018
Figure North America Pulmonary Drug Delivery Systems Sales Growth Rate 2014-2019 (M Units)
Figure North America Pulmonary Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$)
Table North America Pulmonary Drug Delivery Systems Sales by Countries (2014-2019) (M Units)
Table North America Pulmonary Drug Delivery Systems Sales Market Share by Countries (2014-2019)
Figure 2018 North America Pulmonary Drug Delivery Systems Sales Market Share by Countries
Table North America Pulmonary Drug Delivery Systems Revenue by Countries (2014-2019) (Million US$)
Table North America Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Pulmonary Drug Delivery Systems Revenue Market Share by Countries
Figure United States Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure United States Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (M Units)
Figure Canada Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Canada Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Mexico Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Table North America Pulmonary Drug Delivery Systems Sales by Product (2014-2019) (M Units)
Table North America Pulmonary Drug Delivery Systems Sales Market Share by Product (2014-2019)
Figure 2018 North America Pulmonary Drug Delivery Systems Market Share by Product
Table North America Pulmonary Drug Delivery Systems Sales by End User (2014-2019) (M Units)
Table North America Pulmonary Drug Delivery Systems Sales Market Share by End User (2014-2019)
Figure 2018 North America Pulmonary Drug Delivery Systems Market Share by End User
Figure Europe Pulmonary Drug Delivery Systems Sales Growth Rate 2014-2019 (M Units)
Figure Europe Pulmonary Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Pulmonary Drug Delivery Systems Sales by Countries (2014-2019) (M Units)
Table Europe Pulmonary Drug Delivery Systems Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Pulmonary Drug Delivery Systems Sales Market Share by Countries
Table Europe Pulmonary Drug Delivery Systems Revenue by Countries (2014-2019) (Million US$)
Table Europe Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Pulmonary Drug Delivery Systems Revenue Market Share by Countries
Figure Germany Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Germany Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure France Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure France Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure UK Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Italy Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Russia Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Pulmonary Drug Delivery Systems Sales by Product (2014-2019) (M Units)
Table Europe Pulmonary Drug Delivery Systems Sales Market Share by Product (2014-2019)
Figure 2018 Europe Pulmonary Drug Delivery Systems Market Share by Product
Table Europe Pulmonary Drug Delivery Systems Sales by End User (2014-2019) (M Units)
Table Europe Pulmonary Drug Delivery Systems Sales Market Share by End User (2014-2019)
Figure 2018 Europe Pulmonary Drug Delivery Systems Market Share by End User
Figure Asia Pacific Pulmonary Drug Delivery Systems Sales Growth Rate 2014-2019 (M Units)
Figure Asia Pacific Pulmonary Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Pulmonary Drug Delivery Systems Sales by Countries (2014-2019) (M Units)
Table Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Countries
Table Asia Pacific Pulmonary Drug Delivery Systems Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Countries
Figure China Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure China Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Japan Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Korea Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure India Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure India Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Australia Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Indonesia Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Malaysia Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Philippines Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Thailand Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Vietnam Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Singapore Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Pulmonary Drug Delivery Systems Sales by Product (2014-2019) (M Units)
Table Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drug Delivery Systems Market Share by Product
Table Asia Pacific Pulmonary Drug Delivery Systems Sales by End User (2014-2019) (M Units)
Table Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drug Delivery Systems Market Share by End User
Figure Central & South America Pulmonary Drug Delivery Systems Sales Growth Rate 2014-2019 (M Units)
Figure Central & South America Pulmonary Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Pulmonary Drug Delivery Systems Sales by Countries (2014-2019) (M Units)
Table Central & South America Pulmonary Drug Delivery Systems Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pulmonary Drug Delivery Systems Sales Market Share by Countries
Table Central & South America Pulmonary Drug Delivery Systems Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pulmonary Drug Delivery Systems Revenue Market Share by Countries
Figure Brazil Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Brazil Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Argentina Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Pulmonary Drug Delivery Systems Sales by Product (2014-2019) (M Units)
Table Central & South America Pulmonary Drug Delivery Systems Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Pulmonary Drug Delivery Systems Market Share by Product
Table Central & South America Pulmonary Drug Delivery Systems Sales by End User (2014-2019) (M Units)
Table Central & South America Pulmonary Drug Delivery Systems Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Pulmonary Drug Delivery Systems Market Share by End User
Figure Middle East and Africa Pulmonary Drug Delivery Systems Sales Growth Rate 2014-2019 (M Units)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales by Countries (2014-2019) (M Units)
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Countries
Table Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Countries
Figure GCC Countries Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure GCC Countries Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Turkey Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure Egypt Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Pulmonary Drug Delivery Systems Sales Growth Rate (2014-2019) (M Units)
Figure South Africa Pulmonary Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales by Product (2014-2019) (M Units)
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drug Delivery Systems Market Share by Product
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales by End User (2014-2019) (M Units)
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drug Delivery Systems Market Share by End User
Table 3M Company Details
Table 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table 3M Recent Development
Table GSK Company Details
Table GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Cipla Company Details
Table Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cipla Recent Development
Table Chiesi Company Details
Table Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Chiesi Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Aptar Company Details
Table Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Aptar Recent Development
Table Novartis Company Details
Table Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Philips Respironics Company Details
Table Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Philips Respironics Recent Development
Table Omron Healthcare Company Details
Table Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Omron Healthcare Recent Development
Table PARI Company Details
Table Skyepharma Company Details
Table CareFusion Company Details
Table Shanghai Huarui Company Details
Table Taian Character Company Details
Table Chia Tai Tianqing Company Details
Table Global Pulmonary Drug Delivery Systems Sales Forecast by Regions 2019-2025 (M Units)
Table Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by Regions 2019-2025
Table Global Pulmonary Drug Delivery Systems Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Regions 2019-2025
Table Global Pulmonary Drug Delivery Systems Sales Forecast by Product 2019-2025 (M Units)
Table Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by Product 2019-2025
Table Global Pulmonary Drug Delivery Systems Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Pulmonary Drug Delivery Systems Revenue Market Share Forecast by Product 2019-2025
Table Global Pulmonary Drug Delivery Systems Sales Forecast by End User 2019-2025 (M Units)
Table Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by End User 2019-2025
Figure North America Pulmonary Drug Delivery Systems Sales Growth Rate Forecast (2019-2025) (M Units)
Figure North America Pulmonary Drug Delivery Systems Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Pulmonary Drug Delivery Systems Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Europe Pulmonary Drug Delivery Systems Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Pulmonary Drug Delivery Systems Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Asia Pacific Pulmonary Drug Delivery Systems Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Pulmonary Drug Delivery Systems Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Central & South America Pulmonary Drug Delivery Systems Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Sales Growth Rate Forecast (2019-2025) (M Units)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Pulmonary Drug Delivery Systems Value Chain
Table Pulmonary Drug Delivery Systems Customers List
Table Pulmonary Drug Delivery Systems Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Metered Dose Inhalers Market Professional Survey Report 2019
    Published: 14-Nov-2019        Price: US 3500 Onwards        Pages: 112
    The global Metered Dose Inhalers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Metered Dose Inhalers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metered Dose Inhalers market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent co......
  • Global Pulmonary Drug Delivery Systems Market Growth 2019-2024
    Published: 14-Nov-2019        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Pulmonary Drug Delivery Systems market will register a 4.4% CAGR in terms of revenue, the global market size will reach US$ 3102.3 million by 2024, from US$ 2614.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pulmonary Drug Delivery Systems business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities ......
  • Global Smart Inhalers Market Professional Survey Report 2019
    Published: 11-Nov-2019        Price: US 3500 Onwards        Pages: 111
    The global Smart Inhalers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Smart Inhalers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Smart Inhalers market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, ex......
  • Global Inhalation Therapy Nebulizer Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 11-Nov-2019        Price: US 2900 Onwards        Pages: 190
    The Inhalation Therapy Nebulizer market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Inhalation Therapy Nebulizer. Global Inhalation Therapy Nebulizer industry market professional research 2014-2024, is a report which provides the details about industry overview, indus......
  • Global Intrathecal Pumps Market Study 2016-2026, by Segment (Baclofen, Hydromorphone,) , by Market (Pain management, Spasticity management) , by Company (Codman & Shurtleff, Medtronic,)
    Published: 11-Nov-2019        Price: US 1800 Onwards        Pages: 72
    Summary An intrathecal pump is a medical device used to deliver medications directly into the space between the spinal cord and the protective sheath surrounding the spinal cord. Medications such as baclofen, morphine, or ziconotide may be delivered in this manner to minimize the side effects often associated with the higher doses used in oral or intravenous delivery of these drugs. The global Intrathecal Pumps market will reach Volume Million USD in 2019 and with a......
  • Global Inhalation Therapy Nebulizer Market Study 2016-2026, by Segment (Pneumatic Nebulizers, Ultrasonic Nebulizers,) , by Market (COPD, Cystic Fibrosis,) , by Company (PARI GmbH, Omron,)
    Published: 10-Nov-2019        Price: US 1800 Onwards        Pages: 47
    Summary A nebulizer changes medication from a liquid to a mist so that it can be more easily inhaled into the lungs. Nebulizers are particularly effective in delivering asthma medications to infants and small children and to anyone who has difficulty using an asthma inhaler. The global Inhalation Therapy Nebulizer market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of......
  • Global Ultrasonic Nebulizer Market Study 2016-2026, by Segment (Mechanical Ultrasonic Nebulizer, Remote Control Ultrasonic Nebulizer) , by Market (Medical, Beauty, ) , by Company (Besmed, BLS Systems, )
    Published: 07-Nov-2019        Price: US 1800 Onwards        Pages: 55
    Summary The global Ultrasonic Nebulizer market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Mechanical Ultrasonic Nebulizer - Remote Control Ultrasonic Nebulizer Demand Coverage (Market Size & Forecast, Consumer Distribution): - Medical - Beauty - Humidification - Others Company......
  • Global Ultrasonic Nebulizer Mask Market Study 2016-2026, by Segment (Small, Medium, ) , by Market (Hospital, Clinic, ) , by Company (Besmed, BLS Systems, )
    Published: 07-Nov-2019        Price: US 1800 Onwards        Pages: 47
    Summary The global Ultrasonic Nebulizer Mask market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Small - Medium - Large - Extra Large Demand Coverage (Market Size & Forecast, Consumer Distribution): - Hospital - Clinic - Household - Others Company Coverage (Sales d......
  • Global Microneedle Drug Delivery Systems Market Growth (Status and Outlook) 2019-2024
    Published: 25-Oct-2019        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Microneedle Drug Delivery Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Microneedle Drug Delivery Systems business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Microneedle Dru......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs